Catalyst Funds Management Pty »

C4 Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $94k 43k 2.22
2025-06-30 $41k 28k 1.43
2024-06-30 $107k 23k 4.62

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Morgan Stanley
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics